Since humans exhibit specific anti-Gal reactivity, an α-Gal epitope has been developed for the decoration of cancer cells to induce an immune attack and “tumor rejection” (Macher and Galili, 2008; Tanemura et al., 2013; Huai et al., 2016; Anraku et al., 2017). The gene discussed is GAL; the disease is cancer.